Linda Michele Delahanty, M.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Life Style | 54 | 2024 | 3926 | 3.280 |
Why?
|
| Diabetes Mellitus, Type 2 | 67 | 2024 | 12240 | 2.740 |
Why?
|
| Weight Loss | 40 | 2023 | 2710 | 2.710 |
Why?
|
| Risk Reduction Behavior | 14 | 2018 | 1123 | 1.360 |
Why?
|
| Diabetes Mellitus | 21 | 2023 | 5891 | 1.220 |
Why?
|
| Obesity | 37 | 2023 | 13076 | 1.100 |
Why?
|
| Nutrition Therapy | 3 | 2024 | 101 | 1.100 |
Why?
|
| Dietetics | 5 | 2010 | 34 | 1.050 |
Why?
|
| Diet, Fat-Restricted | 8 | 2023 | 328 | 0.880 |
Why?
|
| Telephone | 3 | 2024 | 627 | 0.870 |
Why?
|
| Psychotherapy, Group | 3 | 2018 | 416 | 0.830 |
Why?
|
| Hypoglycemic Agents | 16 | 2020 | 3110 | 0.710 |
Why?
|
| Dietary Services | 5 | 2020 | 17 | 0.680 |
Why?
|
| Metformin | 13 | 2020 | 904 | 0.680 |
Why?
|
| Exercise | 24 | 2022 | 5937 | 0.620 |
Why?
|
| Diet, Reducing | 9 | 2015 | 487 | 0.570 |
Why?
|
| Diet Therapy | 1 | 2018 | 149 | 0.550 |
Why?
|
| Blood Glucose | 19 | 2024 | 6424 | 0.540 |
Why?
|
| Nutrition Assessment | 3 | 2017 | 738 | 0.440 |
Why?
|
| Health Behavior | 10 | 2020 | 2650 | 0.430 |
Why?
|
| Body Mass Index | 23 | 2018 | 13039 | 0.420 |
Why?
|
| Diet | 15 | 2024 | 8086 | 0.410 |
Why?
|
| Insulin | 11 | 2022 | 6599 | 0.410 |
Why?
|
| Nutrition Policy | 3 | 2015 | 467 | 0.400 |
Why?
|
| Overweight | 11 | 2022 | 2444 | 0.380 |
Why?
|
| Blood Glucose Self-Monitoring | 4 | 2022 | 475 | 0.360 |
Why?
|
| Primary Health Care | 5 | 2020 | 4736 | 0.340 |
Why?
|
| Diabetes Complications | 4 | 2008 | 1316 | 0.330 |
Why?
|
| Weight Gain | 4 | 2015 | 2355 | 0.310 |
Why?
|
| Middle Aged | 66 | 2024 | 223009 | 0.290 |
Why?
|
| Motivation | 8 | 2019 | 2018 | 0.290 |
Why?
|
| Metabolic Diseases | 1 | 2014 | 687 | 0.290 |
Why?
|
| Energy Intake | 9 | 2023 | 2141 | 0.290 |
Why?
|
| Primary Prevention | 4 | 2013 | 1187 | 0.280 |
Why?
|
| Cardiovascular Diseases | 9 | 2024 | 15652 | 0.280 |
Why?
|
| Patient Compliance | 8 | 2017 | 2692 | 0.280 |
Why?
|
| Professional Role | 1 | 2010 | 313 | 0.270 |
Why?
|
| Diabetes Mellitus, Type 1 | 6 | 2008 | 3446 | 0.270 |
Why?
|
| Humans | 107 | 2024 | 765968 | 0.270 |
Why?
|
| Body Weight | 8 | 2014 | 4622 | 0.260 |
Why?
|
| Female | 79 | 2024 | 396112 | 0.260 |
Why?
|
| Dietary Fats | 9 | 2020 | 2002 | 0.250 |
Why?
|
| Male | 76 | 2024 | 363698 | 0.250 |
Why?
|
| Polymorphism, Single Nucleotide | 10 | 2020 | 16047 | 0.250 |
Why?
|
| Triglycerides | 3 | 2024 | 2441 | 0.240 |
Why?
|
| Receptor, Melanocortin, Type 4 | 2 | 2017 | 132 | 0.230 |
Why?
|
| Hypercholesterolemia | 2 | 2002 | 1149 | 0.230 |
Why?
|
| Health Promotion | 5 | 2014 | 2208 | 0.220 |
Why?
|
| Food Supply | 2 | 2020 | 544 | 0.210 |
Why?
|
| Prediabetic State | 3 | 2019 | 548 | 0.210 |
Why?
|
| Dietary Carbohydrates | 5 | 2020 | 894 | 0.200 |
Why?
|
| Feeding Behavior | 7 | 2023 | 3212 | 0.200 |
Why?
|
| Randomized Controlled Trials as Topic | 7 | 2022 | 10383 | 0.200 |
Why?
|
| Quality of Life | 6 | 2022 | 13462 | 0.190 |
Why?
|
| Adult | 40 | 2024 | 223044 | 0.190 |
Why?
|
| Postprandial Period | 2 | 2021 | 319 | 0.190 |
Why?
|
| Evidence-Based Medicine | 3 | 2010 | 3685 | 0.180 |
Why?
|
| Motor Activity | 6 | 2015 | 2704 | 0.180 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2017 | 605 | 0.180 |
Why?
|
| Self Care | 4 | 2013 | 800 | 0.170 |
Why?
|
| Genetic Counseling | 3 | 2012 | 634 | 0.170 |
Why?
|
| Aged | 34 | 2024 | 171117 | 0.160 |
Why?
|
| Dietary Fiber | 3 | 2020 | 767 | 0.160 |
Why?
|
| Nutritional Physiological Phenomena | 3 | 2007 | 357 | 0.160 |
Why?
|
| Patient Satisfaction | 2 | 2002 | 3475 | 0.160 |
Why?
|
| Eating | 5 | 2022 | 1540 | 0.140 |
Why?
|
| Stress, Psychological | 4 | 2014 | 4533 | 0.140 |
Why?
|
| Caloric Restriction | 3 | 2018 | 304 | 0.140 |
Why?
|
| Hypoglycemia | 3 | 2017 | 896 | 0.140 |
Why?
|
| PPAR gamma | 2 | 2011 | 483 | 0.140 |
Why?
|
| Menu Planning | 1 | 1996 | 29 | 0.130 |
Why?
|
| Cost-Benefit Analysis | 4 | 2018 | 5526 | 0.130 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2015 | 83 | 0.120 |
Why?
|
| Foods, Specialized | 1 | 2015 | 4 | 0.120 |
Why?
|
| Qualitative Research | 2 | 2024 | 3139 | 0.120 |
Why?
|
| Sleep Deprivation | 1 | 2021 | 845 | 0.120 |
Why?
|
| Patient Education as Topic | 5 | 2012 | 2334 | 0.120 |
Why?
|
| Preventive Health Services | 1 | 2019 | 570 | 0.120 |
Why?
|
| Reminder Systems | 1 | 2018 | 388 | 0.120 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2014 | 3230 | 0.120 |
Why?
|
| Communication Barriers | 1 | 2018 | 418 | 0.120 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 21056 | 0.110 |
Why?
|
| Nutritional Sciences | 3 | 2007 | 148 | 0.110 |
Why?
|
| Personal Autonomy | 1 | 2016 | 315 | 0.110 |
Why?
|
| Early Termination of Clinical Trials | 1 | 2014 | 70 | 0.110 |
Why?
|
| Treatment Outcome | 13 | 2018 | 65188 | 0.110 |
Why?
|
| Follow-Up Studies | 11 | 2020 | 39193 | 0.110 |
Why?
|
| Dysthymic Disorder | 1 | 2013 | 73 | 0.110 |
Why?
|
| Physical Fitness | 2 | 2017 | 742 | 0.110 |
Why?
|
| Genotype | 6 | 2013 | 13024 | 0.100 |
Why?
|
| Program Evaluation | 2 | 2019 | 2499 | 0.100 |
Why?
|
| Fruit | 3 | 2014 | 1166 | 0.100 |
Why?
|
| Vegetables | 3 | 2014 | 1199 | 0.100 |
Why?
|
| Medical Futility | 1 | 2014 | 136 | 0.100 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2014 | 199 | 0.100 |
Why?
|
| Patient Care Team | 3 | 2016 | 2517 | 0.100 |
Why?
|
| New York | 1 | 2014 | 880 | 0.100 |
Why?
|
| Ambulatory Care Facilities | 1 | 2018 | 939 | 0.100 |
Why?
|
| Risk Factors | 13 | 2021 | 74840 | 0.100 |
Why?
|
| Lysophospholipase | 1 | 2011 | 65 | 0.100 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2014 | 350 | 0.090 |
Why?
|
| Cation Transport Proteins | 1 | 2014 | 325 | 0.090 |
Why?
|
| Proinsulin | 1 | 2011 | 135 | 0.090 |
Why?
|
| Hyperglycemia | 2 | 2017 | 1393 | 0.090 |
Why?
|
| Analysis of Variance | 3 | 2013 | 6203 | 0.090 |
Why?
|
| Diabetic Nephropathies | 1 | 1998 | 969 | 0.090 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2011 | 152 | 0.090 |
Why?
|
| Chromans | 2 | 2008 | 116 | 0.090 |
Why?
|
| Waist Circumference | 1 | 2014 | 932 | 0.090 |
Why?
|
| Behavior | 1 | 1993 | 535 | 0.090 |
Why?
|
| Medication Adherence | 3 | 2018 | 2192 | 0.090 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2011 | 169 | 0.090 |
Why?
|
| Depression | 5 | 2014 | 8237 | 0.090 |
Why?
|
| Physical Exertion | 3 | 2014 | 665 | 0.090 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2011 | 262 | 0.090 |
Why?
|
| GPI-Linked Proteins | 1 | 2011 | 472 | 0.080 |
Why?
|
| Counseling | 3 | 2013 | 1551 | 0.080 |
Why?
|
| Alleles | 4 | 2014 | 6897 | 0.080 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 975 | 0.080 |
Why?
|
| Calcium-Binding Proteins | 1 | 2014 | 1077 | 0.080 |
Why?
|
| Dietary Supplements | 1 | 2002 | 3425 | 0.080 |
Why?
|
| Anthropometry | 1 | 2013 | 1338 | 0.070 |
Why?
|
| Thiazolidinediones | 2 | 2008 | 459 | 0.070 |
Why?
|
| United States | 11 | 2019 | 72903 | 0.070 |
Why?
|
| Longitudinal Studies | 4 | 2022 | 14751 | 0.070 |
Why?
|
| Genetic Loci | 2 | 2017 | 2631 | 0.070 |
Why?
|
| Sleep | 1 | 2022 | 4813 | 0.070 |
Why?
|
| Insulin-Secreting Cells | 1 | 2014 | 898 | 0.070 |
Why?
|
| Attitude to Health | 1 | 2015 | 2020 | 0.070 |
Why?
|
| Cholesterol, LDL | 3 | 2024 | 2393 | 0.070 |
Why?
|
| Insulin Resistance | 4 | 2013 | 3985 | 0.070 |
Why?
|
| Body Composition | 2 | 2013 | 2439 | 0.070 |
Why?
|
| Genetic Testing | 4 | 2012 | 3595 | 0.060 |
Why?
|
| Health Literacy | 1 | 2012 | 464 | 0.060 |
Why?
|
| Adolescent | 10 | 2021 | 88835 | 0.060 |
Why?
|
| Proteins | 2 | 2011 | 5995 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2019 | 18071 | 0.060 |
Why?
|
| Dyslipidemias | 1 | 2012 | 869 | 0.060 |
Why?
|
| Diabetes, Gestational | 1 | 2015 | 1263 | 0.060 |
Why?
|
| Administration, Oral | 2 | 2018 | 4015 | 0.060 |
Why?
|
| Research | 1 | 1993 | 1975 | 0.060 |
Why?
|
| Health Education | 1 | 2011 | 1060 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 3 | 2007 | 7425 | 0.060 |
Why?
|
| Incidence | 4 | 2015 | 21480 | 0.060 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 1892 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 9373 | 0.050 |
Why?
|
| Membrane Proteins | 2 | 2011 | 7851 | 0.050 |
Why?
|
| Glucose Tolerance Test | 2 | 2020 | 1180 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2007 | 1740 | 0.050 |
Why?
|
| Depressive Disorder, Major | 2 | 2013 | 4808 | 0.050 |
Why?
|
| Cross-Over Studies | 2 | 2020 | 2108 | 0.050 |
Why?
|
| Behavior Therapy | 1 | 2008 | 884 | 0.050 |
Why?
|
| Telemedicine | 1 | 2019 | 3105 | 0.050 |
Why?
|
| Health Services for the Aged | 1 | 1984 | 265 | 0.050 |
Why?
|
| Prospective Studies | 5 | 2022 | 54802 | 0.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2011 | 4058 | 0.050 |
Why?
|
| Self Efficacy | 1 | 2006 | 642 | 0.050 |
Why?
|
| Regression Analysis | 2 | 2013 | 6322 | 0.050 |
Why?
|
| Dietary Proteins | 2 | 2020 | 959 | 0.050 |
Why?
|
| Cholesterol, HDL | 2 | 2012 | 1811 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2008 | 10729 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2011 | 4247 | 0.040 |
Why?
|
| Health Status Indicators | 1 | 2006 | 966 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2013 | 4913 | 0.040 |
Why?
|
| Genetic Association Studies | 3 | 2015 | 2741 | 0.040 |
Why?
|
| Bulimia | 1 | 2002 | 404 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2019 | 6544 | 0.040 |
Why?
|
| Glycemic Index | 1 | 2021 | 400 | 0.040 |
Why?
|
| Stress, Physiological | 1 | 2006 | 1402 | 0.040 |
Why?
|
| Combined Modality Therapy | 3 | 2015 | 8529 | 0.040 |
Why?
|
| Individuality | 1 | 2020 | 303 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2008 | 2880 | 0.040 |
Why?
|
| C-Peptide | 1 | 2020 | 443 | 0.040 |
Why?
|
| Child | 6 | 2018 | 80564 | 0.040 |
Why?
|
| Glucose Intolerance | 1 | 2002 | 580 | 0.040 |
Why?
|
| Decision Making | 1 | 2012 | 3965 | 0.040 |
Why?
|
| Massachusetts | 2 | 2020 | 8875 | 0.040 |
Why?
|
| Patient Selection | 1 | 2010 | 4255 | 0.040 |
Why?
|
| Food | 1 | 2002 | 764 | 0.030 |
Why?
|
| Psychometrics | 1 | 2006 | 3062 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2017 | 416 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2002 | 2844 | 0.030 |
Why?
|
| Adaptation, Psychological | 1 | 2007 | 2660 | 0.030 |
Why?
|
| Psychological Theory | 1 | 2016 | 172 | 0.030 |
Why?
|
| Depressive Disorder | 1 | 2008 | 3714 | 0.030 |
Why?
|
| Research Design | 1 | 2011 | 6209 | 0.030 |
Why?
|
| Hand Strength | 1 | 2018 | 462 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2002 | 1394 | 0.030 |
Why?
|
| Young Adult | 4 | 2021 | 59889 | 0.030 |
Why?
|
| Patient Dropouts | 1 | 2017 | 410 | 0.030 |
Why?
|
| Menopause | 1 | 2022 | 1659 | 0.030 |
Why?
|
| Metabolic Equivalent | 1 | 2014 | 15 | 0.030 |
Why?
|
| Anticholesteremic Agents | 1 | 2001 | 970 | 0.030 |
Why?
|
| Placebo Effect | 1 | 2018 | 514 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2013 | 12131 | 0.030 |
Why?
|
| Gene Frequency | 2 | 2014 | 3624 | 0.030 |
Why?
|
| Inservice Training | 1 | 2016 | 375 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2007 | 59489 | 0.030 |
Why?
|
| Exercise Therapy | 1 | 2019 | 937 | 0.030 |
Why?
|
| Risk | 2 | 2015 | 9591 | 0.020 |
Why?
|
| Television | 1 | 2015 | 409 | 0.020 |
Why?
|
| Sex Factors | 1 | 2006 | 10603 | 0.020 |
Why?
|
| Glucose | 2 | 2022 | 4335 | 0.020 |
Why?
|
| Social Marketing | 1 | 2011 | 51 | 0.020 |
Why?
|
| Diet Records | 1 | 1993 | 425 | 0.020 |
Why?
|
| Placebos | 2 | 2007 | 1659 | 0.020 |
Why?
|
| Child Behavior | 1 | 2017 | 865 | 0.020 |
Why?
|
| Cohort Studies | 4 | 2017 | 41649 | 0.020 |
Why?
|
| Anxiety | 1 | 2006 | 4671 | 0.020 |
Why?
|
| Time Factors | 4 | 2015 | 40065 | 0.020 |
Why?
|
| Lipids | 1 | 2001 | 3315 | 0.020 |
Why?
|
| Directive Counseling | 1 | 2011 | 171 | 0.020 |
Why?
|
| Group Processes | 1 | 2011 | 224 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 2013 | 12437 | 0.020 |
Why?
|
| Socioeconomic Factors | 2 | 2014 | 7838 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2016 | 1509 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2014 | 1997 | 0.020 |
Why?
|
| Adolescent Behavior | 1 | 2017 | 1185 | 0.020 |
Why?
|
| Dairy Products | 1 | 2012 | 491 | 0.020 |
Why?
|
| Weight Perception | 1 | 2008 | 8 | 0.020 |
Why?
|
| Cross-Sectional Studies | 3 | 2020 | 26318 | 0.020 |
Why?
|
| Interview, Psychological | 1 | 2011 | 812 | 0.020 |
Why?
|
| Sample Size | 1 | 2011 | 845 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2014 | 1237 | 0.020 |
Why?
|
| Diet Surveys | 1 | 2012 | 1159 | 0.020 |
Why?
|
| Lipoproteins | 1 | 2012 | 866 | 0.020 |
Why?
|
| Heterozygote | 1 | 2014 | 2794 | 0.020 |
Why?
|
| Remission Induction | 1 | 2012 | 2411 | 0.020 |
Why?
|
| Comorbidity | 2 | 2014 | 10563 | 0.020 |
Why?
|
| Risk Assessment | 3 | 2012 | 24282 | 0.020 |
Why?
|
| Exercise Test | 1 | 2014 | 2180 | 0.020 |
Why?
|
| Patient-Centered Care | 1 | 2016 | 1458 | 0.020 |
Why?
|
| Interpersonal Relations | 1 | 1993 | 1432 | 0.020 |
Why?
|
| Proline | 1 | 2007 | 453 | 0.020 |
Why?
|
| Sodium, Dietary | 1 | 2009 | 426 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 2780 | 0.020 |
Why?
|
| Nutrition Surveys | 1 | 2013 | 1741 | 0.020 |
Why?
|
| Quantitative Trait Loci | 1 | 2013 | 2140 | 0.020 |
Why?
|
| Fasting | 1 | 2011 | 1606 | 0.010 |
Why?
|
| Citrus | 1 | 1985 | 49 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2020 | 6610 | 0.010 |
Why?
|
| Sickness Impact Profile | 1 | 2006 | 297 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2013 | 1874 | 0.010 |
Why?
|
| Alanine | 1 | 2007 | 612 | 0.010 |
Why?
|
| Speech Therapy | 1 | 1984 | 58 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2011 | 2424 | 0.010 |
Why?
|
| Geriatric Psychiatry | 1 | 1984 | 70 | 0.010 |
Why?
|
| Nursing Care | 1 | 1984 | 68 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 20124 | 0.010 |
Why?
|
| Insulin Infusion Systems | 1 | 1985 | 220 | 0.010 |
Why?
|
| Occupational Therapy | 1 | 1984 | 140 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2018 | 9347 | 0.010 |
Why?
|
| Recurrence | 1 | 2015 | 8501 | 0.010 |
Why?
|
| Social Support | 1 | 2012 | 2192 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1985 | 1600 | 0.010 |
Why?
|
| Finland | 1 | 2004 | 608 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2012 | 3672 | 0.010 |
Why?
|
| Milk | 1 | 1985 | 436 | 0.010 |
Why?
|
| Decision Support Techniques | 1 | 2012 | 2003 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 1993 | 3564 | 0.010 |
Why?
|
| Diabetic Angiopathies | 1 | 2006 | 805 | 0.010 |
Why?
|
| Physical Therapy Modalities | 1 | 1984 | 533 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 2006 | 1731 | 0.010 |
Why?
|
| Sweden | 1 | 2004 | 1381 | 0.010 |
Why?
|
| Critical Care | 1 | 1993 | 2712 | 0.010 |
Why?
|
| Indians, North American | 1 | 2004 | 354 | 0.010 |
Why?
|
| Educational Status | 1 | 2008 | 2513 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 12509 | 0.010 |
Why?
|
| Logistic Models | 1 | 2014 | 13266 | 0.010 |
Why?
|
| Beverages | 1 | 1985 | 819 | 0.010 |
Why?
|
| Linear Models | 1 | 2009 | 5876 | 0.010 |
Why?
|
| Income | 1 | 2008 | 1874 | 0.010 |
Why?
|
| Prognosis | 1 | 2020 | 29922 | 0.010 |
Why?
|
| China | 1 | 2004 | 2385 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 12807 | 0.010 |
Why?
|
| Forecasting | 1 | 2006 | 2936 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2006 | 2892 | 0.010 |
Why?
|
| Hemoglobin A | 1 | 1993 | 84 | 0.010 |
Why?
|
| Health Status | 1 | 2006 | 4080 | 0.010 |
Why?
|
| Pregnancy | 1 | 2015 | 30260 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 15398 | 0.010 |
Why?
|
| Age Factors | 1 | 2006 | 18380 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2004 | 8041 | 0.000 |
Why?
|
| Adipose Tissue | 1 | 1987 | 3312 | 0.000 |
Why?
|
| Animals | 1 | 1985 | 168764 | 0.000 |
Why?
|